Ledger.Open graph →
SEC Form D · filed September 12, 2019

SeLux Diagnostics, Inc

Offering
$9.0M
Sold
$9.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CHARLESTOWN, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Andrew Lemmon · Columbus, OHExec · Director · PromoterMatt Vekasy · Columbus, OHDirectorJeffrey L. Hersh · Greenwich, CTDirectorMark Friess · Portland, ORExec · DirectorShane P. Farritor · Pleasanton, CAExec · PromoterRyan Fliss · Portland, ORDirectorJoe H. Urban · Hayward, CAExec · Director · PromoterDaniel Burnett · Hayward, CADirectorJonathan Bensamoun · BROOKLYN, NYDirectorRonald L. Kirkby · BROOKLYN, NYExec · DirectorStuart L. Ellman · BROOKLYN, NYExec · PromoterPierre Weimerskirch · Grand Duchy of Luxembourg, LuxembourgDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗